Cartalax (AED, T-31 peptide) is a short bioregulatory peptide derived from type XI collagen. Research suggests it may support skin, cartilage, and kidney health by promoting fibroblast activity, boosting cell proliferation, and reducing apoptosis. Studies indicate it can beneficially influence markers tied to aging, such as Ki-67, p53, MMP-9, and SIRT-6, helping restore cellular vitality. As a bioregulator, Cartalax appears to encourage healthier cell function, reduce signs of senescence, and contribute to tissue regeneration and longevity support.